In one patient with type 2 diabetes and obesity treated with oral semaglutide, severe gastric stasis, eosinophilic duodenitis and high bowel obstruction occurred.
In plain wordsOne patient taking oral semaglutide had severe stomach emptying problems, duodenum inflammation and a bowel blockage. One case cannot show cause.
- Peptide
- Semaglutide
- Outcome
- Not applicableEosinophilic duodenitis with high bowel obstruction
- Study
n = 1
- Outcome group
- Gastrointestinal adverse events · Gastrointestinal
- Studied dose
- Dose not stated · oralAs given in this study (human).
Source sentences
The patient, treated with oral semaglutide for type 2 diabetes and obesity, developed progressive upper gastrointestinal symptoms culminating in faecal vomiting. Endoscopic and histological findings revealed marked eosinophilic infiltration of the duodenum.